Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H101 plus HAIC in Unresectable HCC
NCT03780049Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Oct 2018
- Primary completion
- Oct 2023
- Modality
- Gene Editing, Gene Silencing, Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 3 trial of Oncorine in hepatocellular carcinoma (HCC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
Oncorine
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03780049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03780049.